Article Category: COVID-19
Covid-19 Elective Surgery
Date of Publication: April 2020
Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic.
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Date of Publication: April 2020
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. A possbile source of covid 19 entery to lung cells
The role of Vitamin D in the prevention of Coronavirus Disease 2019 infection and mortality
Date of Publication: April 2020
The role of Vitamin D in the prevention of Coronavirus Disease 2019 infection and mortality.
Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
Date of Publication: April 2020
Coronavirus Disease 2019 in Children may be differnet than the same condition in adults.
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
Date of Publication: April 2020
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) causes significant mortality. It is therefore important to minimize the inflammatory response.
The oxygen dissociation curve: quantifying the shift
Date of Publication: February 2003
The oxygen dissociation curve is the model how the exygen delivery takes place at cellular level. This is dependent on a number of varaibles. These included temp, Ph, 2,3 DPG and CO2.
A procedure for determining subject-specific pulse oxygen saturation response
Date of Publication: January 2020
Subject-specific pulse oxygen saturation response has been investigated. This allows for specific conditons to be dtudied. Therfore, better oxygen delivery can be tailored for specific conditions.
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
The novel coronavirus that causes coronavirus disease 2019 (COVID-19). It was first detected in December 2019. As of April 8, the date fo publication of the this article, approximately 1.3 million cases have been reported worldwide. This includes approximately 330,000 in the United States. Since this is an eveolving epidemiological condition then the information information is updated continously
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
Date of Publication: November 2010
Zinc ions are involved in many different cellular processes and have proven crucial for the proper folding and activity of various cellular enzymes and transcription factors.
Increasing the intracellular Zn2+ concentration with zinc-ionophores like pyrithione (PT) can efficiently impair the replication of a variety of RNA viruses, including poliovirus and influenza virus. For some viruses this effect has been attributed to interference with viral polyprotein processing.zinc_Coronavirus
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts
Date of Publication: February 2020
Isolation of cases and contact tracing is used to control outbreaks of infectious diseases. This has been used for COVID-19. Whether this strategy will achieve control depends on characteristics of both the pathogen and the response.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.
Recent Posts
- Weight loss Medications compared to surgery February 20, 2024
- SIPS-SADI and ASMBS December 31, 2023
- Survey December 16, 2023
- Long Term Outcome Survey December 1, 2023
- Weight Loss Injection May 10, 2023